Ulcerative Colitis Clinical Trials in the EU, 2026
The most recently authorised trials on the EU Clinical Trials Information System (CTIS), the single register for every trial run under the EU Clinical Trials Regulation (536/2014). CTIS holds a far larger historical archive than any one list can usefully show — this register states both numbers rather than picking one.
About this register
This register is built from the EU Clinical Trials Information System (CTIS), run by the European Medicines Agency: the single register for every trial authorised under the EU Clinical Trials Regulation (536/2014). CTIS held 12,594 trial records at the last sync on 10 Oct 2026, 03:17 UTC; this register shows the 2,558 most recently authorised of them, a stated recency window rather than the full archive. The list can be downloaded as CSV or JSON.
This page shows the 10 of those trials with a site in Ulcerative Colitis.
How many recently authorised EU trials have a site in Ulcerative Colitis?
10 of the 2,558 most recently authorised trials in this register list a site in Ulcerative Colitis; 1 of them are Phase III. Trials are counted by authorisation on CTIS, not by recruitment status, which CTIS does not publish in the same form as ClinicalTrials.gov.
Summary by phase
| Phase | Trials | Share |
|---|---|---|
| Phase II | 4 | 40% |
| Phase IV | 3 | 30% |
| Phase I | 1 | 10% |
| Phase I/II | 1 | 10% |
| Phase III | 1 | 10% |
Most active sponsors
| Lead sponsor | Trials |
|---|---|
| Centre Hospitalier Regional De Marseille | 1 |
| Eli Lilly & Co. | 1 |
| Granite Bio AG | 1 |
| Grupo Espanol De Trabajo En Enfermedad De Crohn y Colitis Ulcerosa | 1 |
| Mage Biologics Inc. | 1 |
| Microbial Resource Management Health | 1 |
| Pfizer Inc. | 1 |
| Pirkanmaan hyvinvointialue | 1 |
| Universitaetsklinikum Schleswig-Holstein AöR | 1 |
| University Hospital Of Clermont-Ferrand | 1 |